Variant report
Variant | esv11888 |
---|---|
Chromosome Location | chr6:45768255-45768945 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113933892 | chr6:45768255-45768256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139979157 | chr6:45768256-45768257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1375690 | chr6:45768268-45768269 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs560421847 | chr6:45768270-45768271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527781894 | chr6:45768304-45768305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546416741 | chr6:45768315-45768316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564721475 | chr6:45768355-45768356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2396557 | chr6:45768367-45768368 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs535001106 | chr6:45768379-45768380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11754242 | chr6:45768386-45768387 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs143865888 | chr6:45768416-45768417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548161453 | chr6:45768428-45768429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4349810 | chr6:45768429-45768430 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs191109088 | chr6:45768431-45768432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559231274 | chr6:45768443-45768444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577530503 | chr6:45768479-45768480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538414309 | chr6:45768487-45768488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147241500 | chr6:45768500-45768501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575037328 | chr6:45768547-45768548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542679738 | chr6:45768549-45768550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184021698 | chr6:45768562-45768563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11754286 | chr6:45768574-45768575 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs545907806 | chr6:45768641-45768642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564210603 | chr6:45768643-45768644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9296468 | chr6:45768684-45768685 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs190018373 | chr6:45768690-45768691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562678768 | chr6:45768698-45768699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181276035 | chr6:45768705-45768706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9463120 | chr6:45768706-45768707 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs9472568 | chr6:45768722-45768723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs527246812 | chr6:45768732-45768733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552323698 | chr6:45768746-45768747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139674353 | chr6:45768757-45768758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538450865 | chr6:45768760-45768761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115728631 | chr6:45768774-45768775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187095256 | chr6:45768784-45768785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9472569 | chr6:45768791-45768792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
38 | rs34527600 | chr6:45768796-45768797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201537227 | chr6:45768797-45768798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9472570 | chr6:45768804-45768805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116691558 | chr6:45768811-45768812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114164801 | chr6:45768814-45768815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189933516 | chr6:45768819-45768820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576116592 | chr6:45768833-45768834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374230280 | chr6:45768841-45768842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544127964 | chr6:45768878-45768879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9472571 | chr6:45768935-45768936 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16790693 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chordoma | 18071362 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:45763600-45780600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:45767800-45770200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr6:45768200-45776000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:45768400-45770000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr6:45768600-45769600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr6:45768800-45769400 | Enhancers | Adipose Nuclei | Adipose |
7 | chr6:45768800-45770000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr6:45768800-45770000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr6:45768800-45770000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |